GLP-1 Weight Loss Drugs: Benefits, Risks & Rebound Weight Gain
*Introduction - In the ever-evolving world of weight loss and metabolic health, GLP-1 receptor agonists like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) have emerged as revolutionary medications. Originally developed for managing type 2 diabetes, these drugs are now making headlines for their dramatic effects on appetite suppression and body weight reduction. However, alongside the enthusiasm comes growing concern about side effects, long-term safety, and especially rebound weight gain when the medication is stopped. This article explores how GLP-1 drugs work, their benefits, risks, and what the science says about maintaining weight loss after discontinuation. What Are GLP-1 Receptor Agonists? GLP-1: The Science Behind the Name GLP-1 (Glucagon-Like Peptide-1) is a hormone produced in the gut in response to food. It: • Stimulates insulin secretion • Suppresses glucagon (a hormone that raises blood sugar) • Slows gastric emptying • Reduces appetite via brain signa...